For decades, the FDA made it nearly impossible to know which factories were manufacturing your generic medications. ProPublica built a tool to show you. Here’s how we did it.
Moleculin Biotech, Inc., (Nasdaq: MBRX) ('Moleculin” or the 'Company”), a late-stage pharmaceutical company with a broad ...
A U.S. regulatory decision on tolebrutinib will again be delayed while a late-stage trial of the drug for a different form of ...
INB-619, IN8bio’s novel gamma-delta ('γδ”) T cell engager through an Investigational New Drug ('IND”) application ...
The National Medical Commission has asked medical colleges to form committees to monitor prescription practices and ensure ...
TLX591-CDx (Illuccix® in approved jurisdictions, 68Ga-PSMA-11): Positive data from Phase 3 study in Chinese patients provides the basis for near-term NDA submission in China.
Landmark results could pave the way for miv-cel to become the first FDA-approved CAR T-cell therapy for autoimmune disease; Company on track to submit BLA for stiff person syndrome in 1H 2026 Miv-cel ...
Newspoint on MSN
More than 2000 vacancies announced in UP, including medical officer positions; learn how and when to apply
The Uttar Pradesh Public Service Commission (UPPSC) has released a notification for 2158 vacancies for Medical Officers and ...
John Hathaway, Managing Partner of STX, stated that, “Sharp continues to deliver meaningful scientific progress, and we’re increasing our investment commitment because we believe their best work is ...
Introduction This article outlines the research protocol for a multicentre, randomised, controlled study designed to evaluate the therapeutic effect of a modified olfactory training (MOT) based on ...
On0, 2025, FDA reopened registration for the virtual public meetings on food allergen thresholds. The new dates for the virtual meetings are February 18-20, 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback